Sep 03, 09:07
100% of moneycontrol users recommend buying GlaxoSmithKline.
What's your call on GlaxoSmithKline today?
Read 2 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2990.70||-0.16||3000.00||2286.80||50,942.10|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
Thomas Cook (India) Recommended on May 9th 2014
Recommended price 89.00 | Peak from reco 160.80 80.27%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 21,091.05 crore.The company has reported a standalone sales of Rs 654.96 crore and a Net Profit of Rs 98.29 crore for the quarter ended Jun 2014.
The company management includes D S Parekh - Chairman, V Thyagarajan - Vice Chairman, H B Joshipura - Managing Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, S Harford - Director, M B Kapadia - Director, N Kaviratne CBE - Director, R Krishnaswamy - Director, P V Nayak - Director, A N Roy - Director, R C Sequeira - Director, D Sundaram - Director.
It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.
Its Registered office is at Dr. Annie Besant Road , Mumbai,Maharashtra - 400030.
Their Registrars are Karvy Computershare Private Ltd.